Telomere length and <scp>DNA</scp> methylation epitype both provide independent prognostic information in <scp>CLL</scp> patients; data from the <scp>UK CLL4</scp>, <scp>ARCTIC</scp> and <scp>ADMIRE</scp> clinical trials-Reference-Cited by-同舟云学术

Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials

Published:2024-09-10 Issue: Volume: Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Carr Louise¹,Norris Kevin²,Parker Helen¹,Nilsson‐Takeuchi Anna¹,Bryant Dean¹,Amarasinghe Harindra¹,Kadalayil Latha³,Else Monica⁴,Pettitt Andrew⁵^ORCID,Hillmen Peter⁶^ORCID,Schuh Anna⁷,Walewska Renata⁸^ORCID,Baird Duncan M.²^ORCID,Oscier David G.⁸,Oakes Christopher C.⁹,Gibson Jane¹,Pepper Chris¹⁰,Strefford Jonathan C.¹^ORCID

Affiliation:

1. Cancer Genomics, School of Cancer Sciences University of Southampton, Southampton General Hospital Southampton UK

2. Division of Cancer and Genetics, School of Medicine Cardiff University Cardiff UK

3. Faculty of Engineering and Physical Sciences, School of Chemistry University of Southampton Southampton UK

4. Division of Molecular Pathology The Institute of Cancer Research London UK

5. Department of Molecular and Clinical Cancer Medicine University of Liverpool Liverpool UK

6. Section of Experimental Haematology, Leeds Institute of Cancer and Pathology University of Leeds Leeds UK

7. Oxford National Institute for Health Research Biomedical Research Centre/Molecular Diagnostic Centre University of Oxford Oxford UK

8. Division of Haematology University Hospitals Dorset Bournemouth UK

9. Division of Haematology, Department of Internal Medicine The Ohio State University Columbus Ohio USA

10. Brighton and Sussex Medical School University of Sussex Brighton UK

Funder

Cancer Research UK

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19765

Reference14 articles.

1. An Updated Perspective on Current Prognostic and Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of Chemoimmunotherapy and Novel Targeted Therapy

2. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

3. Guideline for the treatment of chronic lymphocytic leukaemia

4. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia

5. A B‐cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact;Queirós AC;Leukemia,2014